PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells.
Zhang KS, Schecker J, Krull A, Riechert E, Jürgensen L, Kamuf-Schenk V, Burghaus J, Kiper L, Cao Ho T, Wöltje K, et al. Sci Rep. 2019 Nov 14; 9(1):16787. Epub 2019 Nov 14.